These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 3356020

  • 1. Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.
    Pislarasu M, Oproiu A, Taranu D, Herberman RB, Sulica A.
    Cancer Res; 1988 May 01; 48(9):2596-603. PubMed ID: 3356020
    [Abstract] [Full Text] [Related]

  • 2. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G, Spuzić I.
    Srp Arh Celok Lek; 1995 May 01; 123(9-10):227-31. PubMed ID: 17974436
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 May 01; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H, Yamaguchi Y, Kadoyama C, Sato N, Fujisawa T.
    Jpn J Clin Oncol; 1983 Mar 01; 13(1):3-13. PubMed ID: 6300483
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
    Balch CM, Tilden AB, Dougherty PA, Cloud GA, Abo T.
    Surgery; 1984 Jan 01; 95(1):63-70. PubMed ID: 6581546
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of different effects of sera of breast cancer patients on the activity of natural killer cells.
    Konjević G, Spuzić I.
    J Clin Lab Immunol; 1992 Jan 01; 38(2):83-93. PubMed ID: 1343351
    [Abstract] [Full Text] [Related]

  • 8. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.
    Cancer Res; 2001 Mar 15; 61(6):2523-32. PubMed ID: 11289125
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
    Steinhauer EH, Doyle AT, Reed J, Kadish AS.
    J Immunol; 1982 Nov 15; 129(5):2255-9. PubMed ID: 7119445
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The effect of serum on NK cell activity].
    Konjević G, Spuzić I.
    Glas Srp Akad Nauka Med; 1991 Nov 15; (41):113-20. PubMed ID: 1916438
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients.
    Kaihara A, Iwagaki H, Gouchi A, Hizuta A, Isozaki H, Takakura N, Tanaka N.
    Res Commun Mol Pathol Pharmacol; 1998 Jun 15; 100(3):283-300. PubMed ID: 9730008
    [Abstract] [Full Text] [Related]

  • 19. Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer.
    Nakagoe T, Sawai T, Tsuji T, Jibiki M, Ohbatake M, Nanashima A, Yamaguchi H, Kurosaki N, Yasutake T, Ayabe H, Arisawa K.
    J Exp Clin Cancer Res; 2001 Mar 15; 20(1):85-90. PubMed ID: 11370835
    [Abstract] [Full Text] [Related]

  • 20. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
    Bloom ET, Babbitt JT, Kawakami K.
    J Immunol; 1986 Jul 01; 137(1):172-8. PubMed ID: 3711665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.